284 related articles for article (PubMed ID: 29395580)
1. A lamellar body mimetic system for the treatment of oxazolone-induced atopic dermatitis in hairless mice.
Moner V; Fernández E; Calpena AC; Garcia-Herrera A; Cócera M; López O
J Dermatol Sci; 2018 May; 90(2):172-179. PubMed ID: 29395580
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.
Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Tagami H
Skin Res Technol; 2004 May; 10(2):122-9. PubMed ID: 15059180
[TBL] [Abstract][Full Text] [Related]
3. Effect of Topically Applied
Jegal J; Park NJ; Kim TY; Choi S; Lee SW; Hang J; Kim SN; Yang MH
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31018627
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis.
Hatano Y; Man MQ; Uchida Y; Crumrine D; Scharschmidt TC; Kim EG; Mauro TM; Feingold KR; Elias PM; Holleran WM
J Invest Dermatol; 2009 Jul; 129(7):1824-35. PubMed ID: 19177139
[TBL] [Abstract][Full Text] [Related]
5. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial.
Jensen JM; Weppner M; Dähnhardt-Pfeiffer S; Neumann C; Bräutigam M; Schwarz T; Fölster-Holst R; Proksch E
Acta Derm Venereol; 2013 Sep; 93(5):515-9. PubMed ID: 23571785
[TBL] [Abstract][Full Text] [Related]
6. Panduratin A, an activator of PPAR-α/δ, suppresses the development of oxazolone-induced atopic dermatitis-like symptoms in hairless mice.
Kim MS; Pyun HB; Hwang JK
Life Sci; 2014 Mar; 100(1):45-54. PubMed ID: 24530874
[TBL] [Abstract][Full Text] [Related]
7. Juniperus chinensis Fruits Attenuate Oxazolone- and 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms in Mice.
Jegal J; Park NJ; Park SA; Bong SK; Jegal H; Kim SN; Yang MH
Biol Pharm Bull; 2018; 41(2):259-265. PubMed ID: 29386485
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.
Man MQ; Hatano Y; Lee SH; Man M; Chang S; Feingold KR; Leung DY; Holleran W; Uchida Y; Elias PM
J Invest Dermatol; 2008 Jan; 128(1):79-86. PubMed ID: 17671515
[TBL] [Abstract][Full Text] [Related]
9. Dioscorea quinqueloba Ameliorates Oxazolone- and 2,4-Dinitrochlorobenzene-induced Atopic Dermatitis Symptoms in Murine Models.
Jegal J; Park NJ; Bong SK; Jegal H; Kim SN; Yang MH
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29206209
[No Abstract] [Full Text] [Related]
10. Ameliorative effects of Juniperus rigida fruit on oxazolone- and 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
Lee S; Park NJ; Bong SK; Jegal J; Park SA; Kim SN; Yang MH
J Ethnopharmacol; 2018 Mar; 214():160-167. PubMed ID: 29258854
[TBL] [Abstract][Full Text] [Related]
11. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
[TBL] [Abstract][Full Text] [Related]
12. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis.
Lee JH; Lee SJ; Kim D; Bang D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1360-8. PubMed ID: 17958842
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption.
Suga H; Oka T; Sugaya M; Sato Y; Ishii T; Nishida H; Ishikawa S; Fukayama M; Sato S
J Invest Dermatol; 2019 Sep; 139(9):1867-1875.e7. PubMed ID: 30905808
[TBL] [Abstract][Full Text] [Related]
14. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
[TBL] [Abstract][Full Text] [Related]
15. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
[TBL] [Abstract][Full Text] [Related]
16. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis.
Pilgram GS; Vissers DC; van der Meulen H; Pavel S; Lavrijsen SP; Bouwstra JA; Koerten HK
J Invest Dermatol; 2001 Sep; 117(3):710-7. PubMed ID: 11564181
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice.
Zheng H; Jeong Y; Song J; Ji GE
Int Immunopharmacol; 2011 Apr; 11(4):511-8. PubMed ID: 21238621
[TBL] [Abstract][Full Text] [Related]
18. Effects of β-carotene on oxazolone-induced atopic dermatitis in hairless mice.
Kake T; Imai M; Takahashi N
Exp Dermatol; 2019 Sep; 28(9):1044-1050. PubMed ID: 31287602
[TBL] [Abstract][Full Text] [Related]
19. Dietary prebiotics promote intestinal Prevotella in association with a low-responding phenotype in a murine oxazolone-induced model of atopic dermatitis.
Laigaard A; Krych L; Zachariassen LF; Ellegaard-Jensen L; Nielsen DS; Hansen AK; Hansen CHF
Sci Rep; 2020 Dec; 10(1):21204. PubMed ID: 33273678
[TBL] [Abstract][Full Text] [Related]
20. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.
van Smeden J; Bouwstra JA
Curr Probl Dermatol; 2016; 49():8-26. PubMed ID: 26844894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
